Corinne Johnson
Stock Analyst at Goldman Sachs
(0.15)
# 4,220
Out of 4,876 analysts
7
Total ratings
16.67%
Success rate
-15.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Initiates: Buy | $59 | $29.03 | +103.24% | 1 | Sep 24, 2024 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $28 → $38 | $22.91 | +65.87% | 2 | Sep 10, 2024 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $25.95 | +92.68% | 3 | May 14, 2024 | |
| IMVT Immunovant | Initiates: Buy | $50 | $16.10 | +210.56% | 1 | Mar 13, 2024 |
Avidity Biosciences
Sep 24, 2024
Initiates: Buy
Price Target: $59
Current: $29.03
Upside: +103.24%
ArriVent BioPharma
Sep 10, 2024
Maintains: Buy
Price Target: $28 → $38
Current: $22.91
Upside: +65.87%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $25.95
Upside: +92.68%
Immunovant
Mar 13, 2024
Initiates: Buy
Price Target: $50
Current: $16.10
Upside: +210.56%